On August 29, 2019 Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, reported that management will participate in the following upcoming investor conferences in September (Press release, Eiger Biopharmaceuticals, AUG 29, 2019, View Source [SID1234539129]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird 2019 Global Healthcare Conference at the InterContinental Barclay in New York City. Eiger will present a corporate update with a live webcast on September 4, 9:05-9:35 PM ET. Eiger will host one-on-one meetings.
CITI 14th Annual Biotech Conference at the Four Seasons Hotel in Boston on September 5. Eiger will host one-on-one meetings.
H.C. Wainwright Global Investment Conference at the Lotte New York Hotel in New York City. Eiger will present a corporate update with a live webcast on September 10, 3:00-3:25 PM ET. Eiger will host one-on-one meetings.
Ladenburg Thalmann 2019 Healthcare Conference at Sofitel Hotel in New York City. Eiger will present a corporate update with a live webcast on September 24, 12:00-12:25 PM ET. Eiger will host one-on-one meetings.
The live webcast of the Baird, H.C. Wainwright, and Ladenburg presentations will be available on the Eiger BioPharmaceuticals website at www.eigerbio.com under the "Investors" tab. A replay of the webcast will be available approximately one hour following the live event.